外用薬受託製造市場規模、シェア、動向分析レポート：製品タイプ別、事業規模別、最終用途別、地域別、セグメント別予測、2025年～2030年

外用薬受託製造市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の外用薬受託製造市場は2030年までに545億5,000万米ドルに達すると予測されています。

同市場は2025～2030年にかけてCAGR 11.05％で成長すると予測されています。現在、外用薬の受託製造の世界市場は、進化する治療ニーズ、アウトソーシング動向、技術の進歩に牽引され、大きな成長を遂げています。さらに、皮膚科疾患の有病率の増加、高齢者の増加、クリーム、ゲル、軟膏、スプレー、経皮パッチなどの非侵襲的ドラッグデリバリー方法への嗜好が相まって、製造受託機関（CMO）のようなアウトソーシングサービスは、コストの最適化、規制遵守の確保、生産能力の強化に不可欠となっています。さらに、CMOは業務の合理化、社内製造経費の削減、製品化のスピードアップを支援する数多くの利点を提供し、市場拡大にさらに貢献しています。さらに、外用薬に対する消費者の需要が高まる中、アウトソーシングは戦略的優先事項となっており、特に半固形製剤や経皮吸収製剤など、専門的な知識と適応性の高いインフラを必要とする製品ラインではその傾向が顕著です。

さらに、市場の成長にはコスト力学が重要な役割を果たしています。価格分析別では、北米では規制基準に準拠した高品質の製造が可能である一方、インド、中国、韓国などのアジア太平洋諸国では、よりコスト効率の高い製造オプションが提供され、その能力も高まっています。労働コストの低下、政府の支援施策、適正製造基準（GMP）に準拠した市場の発展といった要因が、アジア太平洋の市場を活性化しています。さらに、連続製造、ナノカプセル化、先進的均質化、3Dプリンティングなどの技術革新が、製剤精度、バイオアベイラビリティ、バッチ一貫性を向上させています。これらの進歩は、CMOが複雑な製品需要に対応し、有効性とカスタマイズに対する消費者の期待の高まりに応えることを支援しています。

さらに、価格設定モデルは、業績と財務結果を一致させることで進化しています。しかし、輸入医薬品有効成分（API）や賦形剤に対する米国の関税のような外的要因は、サプライチェーンにコスト圧力をもたらし、特に輸出企業に影響を及ぼしています。こうした課題にもかかわらず、同市場は予測期間中に成長が見込まれます。同様に、戦略的イニシアティブと製品上市の加速が市場を牽引しています。例えば、2024年7月、Arcutis BIoTherapeutics, Inc.は、成人と6歳以下の小児における軽度から中等度のアトピー性皮膚炎の治療を適応とするZORYVEクリーム0.15%を米国で発売すると発表しました。この新しいクリームは、1日1回塗布するもので、ステロイドを含まず、症状を素早く緩和し、かゆみを軽減するため、より長期的な管理が可能になります。このような技術革新は、予測期間中に市場をさらに推進すると予想されます。

外用薬受託製造市場レポートハイライト

• 半固形製剤セグメントが市場を独占し、2024年のシェアは65.54%でした。この成長の原動力は、皮膚疾患の有病率の増加、標的治療に対する患者の嗜好、半固形製剤の利便性、治療・化粧品両セグメントにおける薬剤吸収性・安定性・審美性の向上に対する需要です。
• 事業規模別では、2024年には商業セグメントが最大の市場シェアを占めました。アウトソーシングの動向の高まり、皮膚科学的治療や経皮療法に対する需要の増加、規制への対応、コスト効率の向上、専門的な製造ノウハウを必要とする製剤の複雑化などがその要因です。
• 2024年の最終用途別市場シェアは、製薬企業が最も高いです。これらの企業は、非侵襲的治療、慢性皮膚疾患の治療、患者のコンプライアンス向上、美容皮膚科や先進的経皮ドラッグデリバリーシステムにおける機会の増加などの需要増加により、CMOサービスを活用しています。
• 北米は、米国やカナダなどで製造受託機関（CMO）の数が増加しているため、予測期間中にCAGR 10.37％の成長率を記録すると予想されます。さらに、熟練した労働力の利用可能性と規制シナリオは、この地域における市場の拡大に大きく貢献すると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 外用薬受託製造市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/補助市場展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 価格モデル分析
• 技術
• 市場分析ツール
  • ポーターのファイブフォース分析
  • SWOT分析によるPESTEL
  • COVID-19の影響分析

第4章 外用薬受託製造市場：製品タイプ別、推定・動向分析

• 外用薬受託製造市場（製品タイプ別）：セグメントダッシュボード
• 外用薬受託製造市場（製品タイプ別）：変動分析
• 製品タイプ別、2018～2030年
• 半固形製剤
  • クリーム
  • 軟膏
  • ゲル
  • その他
• 液体製剤
• 固形製剤
• 経皮吸収型製品

第5章 外用薬受託製造市場：事業規模別、推定・動向分析

• 外用薬受託製造市場（事業規模別）：セグメントダッシュボード
• 外用薬受託製造市場（事業規模別）：変動分析
• 事業規模別、2018～2030年
• 臨床
• 商用

第6章 外用薬受託製造市場：最終用途別、推定・動向分析

• 外用薬受託製造市場（最終用途別）：セグメントダッシュボード
• 外用薬受託製造市場（最終用途別）：変動分析
• 最終用途別、2018～2030年
• 製薬会社
• バイオ医薬品企業
• その他

第7章 外用薬受託製造市場：地域別、推定・動向分析

• 地域別市場シェア分析、2024年と2030年
• 地域別市場ダッシュボード
• 世界地域市場のスナップショット
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • スウェーデン
  • デンマーク
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • タイ
  • 韓国
  • オーストラリア
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 市場参入企業の分類
• 企業市場シェア/評価分析、2024年
• 企業プロファイル
  • MedPharm
  • DPT Laboratories Ltd
  • Cambrex Corporation
  • Kindeva Drug Delivery
  • AbbVie Contract Manufacturing
  • NextPharma
  • Catalent Pharma Solutions
  • Thermo Fisher Scientific
  • Lonza Group
  • The Lubrizol Corporation
  • SGS SA
  • Bora Pharmaceutical CDMO

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
• Table 4 Global Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
• Table 5 Global Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
• Table 6 Global Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Region, 2018 - 2030 (USD Million)
• Table 7 North America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
• Table 8 North America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
• Table 9 North America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
• Table 10 North America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 11 U.S. Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
• Table 12 U.S. Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
• Table 13 U.S. Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 14 Canada Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
• Table 15 Canada Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
• Table 16 Canada Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 17 Mexico Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
• Table 18 Mexico Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
• Table 19 Mexico Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 20 Europe Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
• Table 21 Europe Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
• Table 22 Europe Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
• Table 23 Europe Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 24 UK Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
• Table 25 UK Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
• Table 26 UK Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 27 Germany Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
• Table 28 Germany Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
• Table 29 Germany Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 30 France Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
• Table 31 France Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
• Table 32 France Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 33 Italy Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
• Table 34 Italy Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
• Table 35 Italy Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 36 Spain Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
• Table 37 Spain Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
• Table 38 Spain Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 39 Sweden Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
• Table 40 Sweden Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
• Table 41 Sweden Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 42 Denmark Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
• Table 43 Denmark Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
• Table 44 Denmark Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 45 Norway Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
• Table 46 Norway Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
• Table 47 Norway Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
• Table 51 Asia Pacific Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 52 Japan Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
• Table 53 Japan Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
• Table 54 Japan Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 55 China Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
• Table 56 China Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
• Table 57 China Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 58 India Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
• Table 59 India Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
• Table 60 India Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 61 Thailand Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
• Table 62 Thailand Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
• Table 63 Thailand Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 64 South Korea Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
• Table 65 South Korea Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
• Table 66 South Korea Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 67 Australia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
• Table 68 Australia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
• Table 69 Australia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 70 Latin America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
• Table 71 Latin America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
• Table 72 Latin America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
• Table 73 Latin America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 74 Brazil Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
• Table 75 Brazil Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
• Table 76 Brazil Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 77 Argentina Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
• Table 78 Argentina Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
• Table 79 Argentina Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 80 Middle East & Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
• Table 81 Middle East & Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
• Table 82 Middle East & Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
• Table 83 Middle East & Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 84 South Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
• Table 85 South Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
• Table 86 South Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
• Table 89 Saudi Arabia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 90 UAE Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
• Table 91 UAE Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
• Table 92 UAE Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
• Table 93 Kuwait Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Product Type, 2018 - 2030 (USD Million)
• Table 94 Kuwait Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by Scale of Operation, 2018 - 2030 (USD Million)
• Table 95 Kuwait Topical Drugs Contract Manufacturing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Market formulation & validation
• Fig. 6 Commodity flow analysis
• Fig. 7 Value-chain-based sizing & forecasting
• Fig. 8 QFD model sizing & forecasting
• Fig. 9 Bottom-up approach
• Fig. 10 Market snapshot
• Fig. 11 Segment snapshot 1
• Fig. 12 Segment snapshot 2
• Fig. 13 Competitive landscape snapshot
• Fig. 14 Parent market outlook, 2024 (USD Billion)
• Fig. 15 Ancillary market outlook, 2024 (USD Billion)
• Fig. 16 Topical Drugs Contract Manufacturing Market dynamics
• Fig. 17 Porter's five forces analysis
• Fig. 18 PESTEL analysis
• Fig. 19 Topical Drugs Contract Manufacturing Market: Product Type outlook and key takeaways
• Fig. 20 Topical Drugs Contract Manufacturing Market: Product Type movement analysis
• Fig. 21 Semi-solid Formulations Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 22 Creams Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 23 Ointments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 24 Gel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 25 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Liquid Formulations Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Solid Formulations Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Transdermal Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 29 Topical Drugs Contract Manufacturing Market: Scale of Operation outlook and key takeaways
• Fig. 30 Topical Drugs Contract Manufacturing Market: Scale of Operation movement analysis
• Fig. 31 Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Commercial Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Topical Drugs Contract Manufacturing Market: End Use outlook and key takeaways
• Fig. 34 Topical Drugs Contract Manufacturing Market: End Use movement analysis
• Fig. 35 Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Biopharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Regional Marketplace: Key Takeaways
• Fig. 39 North America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Key country dynamics
• Fig. 41 U.S. Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Key country dynamics
• Fig. 43 Canada Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Key country dynamics
• Fig. 45 Mexico Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Europe Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Key country dynamics
• Fig. 48 UK Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Key country dynamics
• Fig. 50 Germany Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Key country dynamics
• Fig. 52 France Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Key country dynamics
• Fig. 54 Italy Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Key country dynamics
• Fig. 56 Spain Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Key country dynamics
• Fig. 58 Sweden Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Key country dynamics
• Fig. 60 Denmark Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Key country dynamics
• Fig. 62 Norway Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Asia Pacific Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Key country dynamics
• Fig. 65 Japan Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 66 Key country dynamics
• Fig. 67 China Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 68 Key country dynamics
• Fig. 69 India Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 70 Key country dynamics
• Fig. 71 Thailand Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 72 Key country dynamics
• Fig. 73 South Korea Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 74 Key country dynamics
• Fig. 75 Australia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 76 Latin America Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 77 Key country dynamics
• Fig. 78 Brazil Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 79 Key country dynamics
• Fig. 80 Argentina Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 81 MEA Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 82 Key country dynamics
• Fig. 83 South Africa Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 84 Key country dynamics
• Fig. 85 Saudi Arabia Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 86 Key country dynamics
• Fig. 87 UAE Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 88 Key country dynamics
• Fig. 89 Kuwait Topical Drugs Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 90 Key company categorization
• Fig. 91 Service heat map analysis
• Fig. 92 Strategic framework

Topical Drugs Contract Manufacturing Market Growth & Trends:

The global topical drugs contract manufacturing market is expected to reach USD 54.55 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 11.05% from 2025 to 2030. Currently, the global market for contract manufacturing of topical drugs is currently experiencing significant growth, driven by evolving therapeutic needs, outsourcing trends, and advancements in technology. Moreover, with the increasing prevalence of dermatological conditions, coupled with a rising geriatric population and a preference for non-invasive drug delivery methods such as creams, gels, ointments, sprays, and transdermal patches has made outsourcing services like Contract Manufacturing Organizations (CMOs) essential for optimizing costs, ensuring regulatory compliance, and enhancing production capabilities. In addition, CMOs offer numerous advantages that support streamline operations, lower in-house manufacturing expenses, and speed up product commercialization, further contributing to market expansion. In addition, with the rising consumer demand for topical drugs, outsourcing has become a strategic priority, particularly for semi-solid and transdermal product lines that require specialized expertise and adaptable infrastructure.

Furthermore, cost dynamics play a crucial role in the growth of the market. Based on the pricing analysis, the North America provides high-quality manufacturing that complies with regulatory standards, while the Asia Pacific's countries like India, China, and South Korea offers more cost-effective production options with growing capabilities. Factors such as lower labor costs, supportive government policies, and a developing infrastructure complaint with Good Manufacturing Practices (GMP) are fueling the market in Asia Pacific. Furthermore, technological innovations such as continuous manufacturing, nanoencapsulation, advanced homogenization, and 3D printing are improving formulation accuracy, bioavailability, and batch consistency. These advancements support the CMOs to meet complex product demands and meet rising consumer expectations for efficacy and customization.

Furthermore, pricing models are evolving with aligning financial results with performance. However, external factors like U.S. tariffs on imported active pharmaceutical ingredients (APIs) and excipients have created cost pressures in the supply chain, particularly impacting exporters. Despite these challenges, the market is expected to witness growth during the forecast period. Likewise, strategic initiatives and accelerating product launches drive the market. For instance, in July 2024, Arcutis Biotherapeutics, Inc. announced the release of ZORYVE cream 0.15% for the treatment of mild to moderate atopic dermatitis in both adults and children under 6 in the U.S. This new cream, which is applied once daily and contains no steroids, provides quick relief from symptoms and reduces itching, allowing for better long-term management of the condition. Such innovations are expected to further propel the market during the forecast period.

Topical Drugs Contract Manufacturing Market Report Highlights:

• The semi-solid formulations segment dominated the market, with a share of 65.54% in 2024. This growth is driven by the increasing prevalence of skin diseases, patient preferences for targeted therapies, the convenience of semi-solid formulations, and the demand for improved drug absorption, stability, and aesthetic appeal within both therapeutic and cosmetic sectors.
• Based on the scale of operation, the commercial segment held the largest market share in 2024, attributed to the growing trend toward outsourcing, increased demand for dermatological and transdermal therapies, regulatory compliance, increased cost efficiency, and the rising complexity of formulations that require specialized manufacturing expertise.
• The pharmaceutical companies segment held the largest market share in 2024 based on end-use. These companies leverage CMO services due to increasing demand for non-invasive therapies, treatments for chronic skin conditions, improved patient compliance, and opportunities within cosmetic dermatology and advanced transdermal drug delivery systems.
• North America is expected to register a growth rate of 10.37% CAGR over the forecast period due to the rising number of contract manufacturing organizations(CMOs) in countries such as the U.S. and Canada. In addition, the availability of a skilled workforce and regulatory scenarios are expected to significantly contribute to the market's expansion in this region.

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product Type
  • 1.2.2. Scale of Operation
  • 1.2.3. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information Or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
  • 1.7.2. Parent Market Analysis
• 1.8. List Of Secondary Sources
• 1.9. List Of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Topical Drugs Contract Manufacturing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Pricing Model Analysis
• 3.4. Technology Landscape
• 3.5. Market Analysis Tools
  • 3.5.1. Porter's Five Force Analysis
  • 3.5.2. PESTEL by SWOT Analysis
  • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Topical Drugs Contract Manufacturing Market: Product Type Estimates & Trend Analysis

• 4.1. Topical Drugs Contract Manufacturing Market, By Product Type: Segment Dashboard
• 4.2. Topical Drugs Contract Manufacturing Market, By Product Type: Movement Analysis
• 4.3. Topical Drugs Contract Manufacturing Market Estimates & Forecasts, By Product Type, 2018 - 2030
• 4.4. Semi-Solid Formulations
  • 4.4.1. Semi-Solid Formulations Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Creams
    • 4.4.2.1. Creams Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.3. Ointments
    • 4.4.3.1. Ointments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.4. Gel
    • 4.4.4.1. Gel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.5. Others
    • 4.4.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Liquid Formulations
  • 4.5.1. Liquid Formulations Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Solid Formulations
  • 4.6.1. Solid Formulations Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Transdermal Products
  • 4.7.1. Transdermal Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Topical Drugs Contract Manufacturing Market: Scale of Operation Estimates & Trend Analysis

• 5.1. Topical Drugs Contract Manufacturing Market, By Scale of Operation: Segment Dashboard
• 5.2. Topical Drugs Contract Manufacturing Market, By Scale of Operation: Movement Analysis
• 5.3. Topical Drugs Contract Manufacturing Market Estimates & Forecasts, By Scale of Operation, 2018 - 2030
• 5.4. Clinical
  • 5.4.1. Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Commercial
  • 5.5.1. Commercial Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Topical Drugs Contract Manufacturing Market: End Use Estimates & Trend Analysis

• 6.1. Topical Drugs Contract Manufacturing Market, By End Use: Segment Dashboard
• 6.2. Topical Drugs Contract Manufacturing Market, By End Use: Movement Analysis
• 6.3. Topical Drugs Contract Manufacturing Market Estimates & Forecasts, By End Use, 2018 - 2030
• 6.4. Pharmaceutical Companies
  • 6.4.1. Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Biopharmaceutical Companies
  • 6.5.1. Biopharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Others
  • 6.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Topical Drugs Contract Manufacturing Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. North America
  • 7.4.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. U.S
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Framework
    • 7.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Framework
    • 7.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Framework
    • 7.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Regulatory Framework
    • 7.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Regulatory Framework
    • 7.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Sweden
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Denmark
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Competitive Scenario
    • 7.5.8.3. Regulatory Framework
    • 7.5.8.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. Norway
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Competitive Scenario
    • 7.5.9.3. Regulatory Framework
    • 7.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. Thailand
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. South Korea
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Australia
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Competitive Scenario
    • 7.8.4.3. Regulatory Framework
    • 7.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Competitive Scenario
    • 7.8.5.3. Regulatory Framework
    • 7.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Company Market Share/Assessment Analysis, 2024
• 8.3. Company Profiles
  • 8.3.1. MedPharm
    • 8.3.1.1. Company Overview
    • 8.3.1.2. Financial Performance
    • 8.3.1.3. Service Benchmarking
    • 8.3.1.4. Strategic Initiatives
  • 8.3.2. DPT Laboratories Ltd
    • 8.3.2.1. Company Overview
    • 8.3.2.2. Financial Performance
    • 8.3.2.3. Service Benchmarking
    • 8.3.2.4. Strategic Initiatives
  • 8.3.3. Cambrex Corporation
    • 8.3.3.1. Company Overview
    • 8.3.3.2. Financial Performance
    • 8.3.3.3. Service Benchmarking
    • 8.3.3.4. Strategic Initiatives
  • 8.3.4. Kindeva Drug Delivery
    • 8.3.4.1. Company Overview
    • 8.3.4.2. Financial Performance
    • 8.3.4.3. Service Benchmarking
    • 8.3.4.4. Strategic Initiatives
  • 8.3.5. AbbVie Contract Manufacturing
    • 8.3.5.1. Company Overview
    • 8.3.5.2. Financial Performance
    • 8.3.5.3. Service Benchmarking
    • 8.3.5.4. Strategic Initiatives
  • 8.3.6. NextPharma
    • 8.3.6.1. Company Overview
    • 8.3.6.2. Financial Performance
    • 8.3.6.3. Service Benchmarking
    • 8.3.6.4. Strategic Initiatives
  • 8.3.7. Catalent Pharma Solutions
    • 8.3.7.1. Company Overview
    • 8.3.7.2. Financial Performance
    • 8.3.7.3. Service Benchmarking
    • 8.3.7.4. Strategic Initiatives
  • 8.3.8. Thermo Fisher Scientific
    • 8.3.8.1. Company Overview
    • 8.3.8.2. Financial Performance
    • 8.3.8.3. Service Benchmarking
    • 8.3.8.4. Strategic Initiatives
  • 8.3.9. Lonza Group
    • 8.3.9.1. Company Overview
    • 8.3.9.2. Financial Performance
    • 8.3.9.3. Service Benchmarking
    • 8.3.9.4. Strategic Initiatives
  • 8.3.10. The Lubrizol Corporation
    • 8.3.10.1. Company Overview
    • 8.3.10.2. Financial Performance
    • 8.3.10.3. Service Benchmarking
    • 8.3.10.4. Strategic Initiatives
  • 8.3.11. SGS S.A.
    • 8.3.11.1. Company Overview
    • 8.3.11.2. Financial Performance
    • 8.3.11.3. Service Benchmarking
    • 8.3.11.4. Strategic Initiatives
  • 8.3.12. Bora Pharmaceutical CDMO
    • 8.3.12.1. Company Overview
    • 8.3.12.2. Financial Performance
    • 8.3.12.3. Service Benchmarking
    • 8.3.12.4. Strategic Initiatives